Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 277-283

  Gartside, S E ^a   McQuade, R ^a   Sharp, T ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ELECTROSTIMULATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; FRONTAL LOBE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 0030432240     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. AGHAJANIAN, G. K. AND VANDERMAELEN, C. P.: Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure. J. Neurosci. 2: 1786-1792, 1982.
2. AGHAJANIAN, G. K., WANG, R. Y. AND BARABAN, J.: Serotonergic and non-serotonergic neurons of the dorsal raphé: Reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res. 183: 169-175, 1978.
3. AGID, Y., JAVOY, F. AND GLOWINSKI, J.: Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature New Biol. 245: 150-151, 1973.
4. ALLEN, R. P., MCCann, U. D. and Ricaurte, G. A.: Persistent effects of (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. Sleep 16: 560-564, 1993.
5. BATTAGLIA, G., SHARKEY, J., KUHAR, M. J. AND DE SOUZA, E. B.: Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): Assessment using quantitative autoradiography. Synapse 8: 249-260, 1991.
6. 3H]paroxetine-labeled uptake sites. J. Pharmacol. Exp. Ther. 242: 911-916, 1987.
7. BAUMGARTEN, H. G., JENNER, S. AND KLEMM, H. P.: Serotonin neurotoxins: Recent advances in the mode of administration and molecular mechanism of action. J. Physiol. (Paris) 77: 309-314, 1982.
8. BENDOTTI, C., SERVADIO, A., FORLONI, G., ANGERETTI, N. AND SAMANIN, R.: Increased tryptophan hydroxylase mRNA in raphé serotonergic neurons spared by 5,7-dihydroxytryptamine. Brain Res. Mol. Brain Res. 8: 343-348, 1990.
9. CHIODO, L. A., ACHESON, A. L., ZIGMOND, M. J. AND STRICKER, E. M.: Subtotal destruction of central noradrenergic projections increases the firing rate of locus ceruleus cells. Brain Res. 264: 123-126, 1983.
10. COMMINS, D. L., VOSMER, G., VIRUS, R. M., WOOLVERTON, W. L., SCHUSTER, C. R. AND SEIDEN, L. S.: Biochemical and histological evidence that methyl-enedioxymetamphetamine (MDMA) is toxic to neurons in the rat brain. J. Pharmacol. Exp. Ther. 241: 338-345, 1987.
11. 1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115: 1064-1070, 1995.
12. HAJÓS, M., GARTSIDE, S. E. AND SHARP, T.: Inhibition of median and dorsal raphé neurones by the selective 5-HT reuptake inhibitor paroxetine. Naunyn-Schmeideberg's Arch. Pharmacol. 351: 624-629, 1995a.
13. HAJÓS, M., GARTSIDE, S. E., VILLA, A. E. P. AND SHARP, T.: Evidence of a repetitive (burst) firing pattern in a sub-population of 5-HT neurons in the dorsal and median raphé nuclei of the rat. Neuroscience 69: 189-197, 1995b.
14. HAJÓS, M. AND SHARP, T.: A 5-hydroxytryptamine lesion markedly reduces the incidence of burst-firing dorsal raphé neurones in the rat. Neurosci. Lett. 204: 1-4, 1996.
15. HAYNER, G. N. AND McKinney, H.: MDMA: The dark side of ecstasy. J. Psychoactive Drugs 18: 341-347, 1986.
16. HOLLERMAN, J. R. AND GRACE, A. A.: The effects of dopamine depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons. Brain Res. 538: 203-212, 1990.
17. JACOBS, B. L. AND AZMITIA, E.: Structure and function of the brain serotonin system. Physiol. Rev. 72: 165-229, 1992.
18. KALÉN, P., STRECKER, R. E., ROSENGREN, E. AND BJÖRKLUND, A.: Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J. Neurochem. 51: 1422-1435, 1988.
19. KIRBY, L. G,. KREISS, D. S,. SINGH, A. AND LUCKI, I.: Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse 20: 99-105, 1995.
20. KRYSTAL, J. H., PRICE, L. H., OPSAHL, C., RICAURTE, G. A. AND HENINGER, G. R.: Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: Effects on mood and neuropsychological function? Am. J. Drug Alcohol Abuse 18: 331-341, 1992.
21. MAMOUNAS, L. A. AND MOLLIVER, M. E.: Evidence for dual serotonergic projections to neocortex: Axons from the dorsal and median raphé nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp. Neurol. 102: 23-36, 1988.
22. MAMOUNAS, L. A., MULLEN, C. A., O'HEARN, E. AND MOLLIVER, M. E.: Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5-HT axons terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol. 314: 558-586, 1991.
23. MCCANN, U. D. AND RICAURTE, G. A.: Lasting neuropsychiatric sequelae of (±) methylenedioxymethamphetamine ("ecstasy") in recreational users. J. Clin. Psychopharmacol. 11: 302-305, 1991.
24. MCCANN, U. D., RIDENOUR, A., SHAHAM, Y. AND RICAURTE, G. A.: Serotonin neurotoxicity after (±) 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"): A controlled study in humans. Neuropsychopharmacology 10: 1239-138, 1994.
25. MCGUIRE, P. AND FAHY, T.: Chronic paranoid psychosis after misuse of MDMA ("ecstasy"). Br. Med. J. 302: 697, 1991.
26. MCQUADE, R. AND SHARP, T.: Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphé nuclei: Effect of a neurotoxic amphetamine. Neuroscience 68: 1079-1088, 1995.
27. MOLLIVER, M. E., BERGER, U. V., MAMOUNAS, L. A., MOLLIVER, D. C., O'HEARN, E. AND WILSON, M. A.: Neurotoxicity of MDMA and related compounds: Anatomic studies. Ann. N.Y. Acad. Sci. 600: 649-661, 1990.
28. O'HEARN, E., BATTAGLIA, G., DE SOUZA, E. B., KUHAR, M. J. AND MOLLIVER, M. E.: Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity. J. Neurosci. 8: 2788-2803, 1988.
29. PALLANTI, S. AND MAZZI, D.: MDMA (Ecstasy) precipitation of panic disorder. Biol. Psychiatry 32: 91-95, 1992.
30. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982.
31. POLAND, R. E.: Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats. Neuropharmacology 29: 1099-1101, 1990.
32. RICAURTE, G. A., MARKOWSKA, A. L., WENK, G. L., HATZIDMITRIOU, G., WLOS, J. AND OLTON, D. S.: 3,4-Methylenedioxymethamphetamine, serotonin and memory. J. Pharmacol. Exp. Ther. 266: 1097-1105, 1993.
33. ROBINSON, T. E., CASTANEDA, E. AND WHISHAW, I. Q.: Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade. Neuropsychopharmacology 8: 77-85, 1993.
34. SCHMIDT, C. J.: Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240: 1-7, 1987.
35. SERIES, H. G., COWEN, P. J. AND SHARP, T.: p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology 116: 508-514, 1994.
36. SERIES, H. G., LE MASURIER, M., GARTSIDE, S. E., FRANKLIN, M. AND SHARP, T.: Behavioural and neuroendocrine responses to d-fenfluramine in rats treated with neurotoxic amphetamines. J. Psychopharmacol. 9: 214-22, 1995.
37. 1A autoreceptors. Neurosci. Lett. 132: 179-182, 1991.
38. SHARP, T., BRAMWELL, S. R., CLARK, D. AND GRAHAME-SMITH, D. G.: In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: Changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurosci. 53: 234-240, 1989.
39. SHARP, T., BBAMWELL, S. R. AND GRAHAME-SMITH, D. G.: Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphé nucleus as detected by microdialysis: Sensitivity to tetrodotoxin, calcium and calcium antagonists. Neuroscience 39: 629-637, 1990.
40. SLIKKER, W., JR., HOLSON, R. R., ALI, S. F., KOLTA, M. G., PAULE, M. G., SCALLET, A. C., MCMILLAN, D. E., BAILEY, J. R., HONG, J. S. AND SCALZO, F. M.: Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 10: 529-542, 1989.
41. STACHOWIAK, M. K., STRICKER, E. M., JACOBY, J. H. AND ZIGMOND, M. J.: Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem. Pharmacol. 35: 1241-1248, 1986.
42. STONE, D. M., STAHL, D. C., HANSON, G. R. AND GIBB, J. W.: The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128: 41-48, 1986.
43. ZIGMOND, M. J., ABERCROMBIE, E. D., BERGER, T. W., GRACE, A. A. AND STRICKER, E. M.: Compensations after lesions of central dopaminergic neurons: Some clinical and basic implications. Trends Neurosci. 13: 290-296, 1990.